Beneficial Ownership Report · SCHEDULE 13D/A
Exicure, Inc.
XCURNASDAQEQUITYCurrent
Beneficial Ownership Report
Structured filing — SCHEDULE 13D/A
primary_doc.xml
Amendment · This filing reports the amendment as submitted.
Subject company
- Company
- EXICURE, INC.
- Company CIK
- 0001698530
- Street
- 2430 N. HALSTED ST.
- City
- CHICAGO
- State / country code
- IL
- Postal code
- 60614
Statement details
- Amendment number
- 5
- Security class
- Common Stock
- Event date
- 01/21/2026
- Previously filed indication
- false
Authorized notification person 1
- Name
- Dario Lee
- Phone
- 2368386944
- Street
- 1500 W Georgia st
- Street (continued)
- Suite 1323
- City
- Vancouver
- State / country code
- A1
- Postal code
- V7Y1C6
Reporting person 1
- Name
- Exicure HiTron Inc.
- Reporting person CIK
- 0002046701
- No reporting person CIK indication
- N
- Citizenship / organization
- M5
- Reporting person type
- CO
- Source of funds code
- OO
- Legal proceedings indication
- N
- Aggregate amount owned
- 1,598,947.00
- Percent of class
- 25.1
- Sole voting power
- 1,598,947.00
- Shared voting power
- 0.00
- Sole dispositive power
- 1,598,947.00
- Shared dispositive power
- 0.00
- Aggregate excludes certain shares
- N
Item 1
Issuer
EXICURE, INC.
Security title
Common Stock
Principal address
Comment
This Amendment No. 5 (this Amendment) to the statement on Schedule 13D with respect to the beneficial ownership of shares of common stock, par value $0.0001 per share (the Shares), of Exicure, Inc., a Delaware corporation (the Issuer), is being filed by Exicure HiTron Inc., a South Korean corporation (the Reporting Person). This Amendment amends and supplements the beneficial ownership statement on Schedule 13D originally filed on November 29, 2024, as amended by Amendment No. 1 filed on March 26, 2025, Amendment No. 2 filed on September 9, 2025, Amendment No. 3 filed on January 9, 2026, and Amendment No. 4 filed on January 16, 2026 (collectively, the Original Statement), as set forth below. All capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Original Statement. Except as expressly amended hereby, the Original Statement remains unchanged.
Item 3
Source of funds
Item 3 of the Original Statement is hereby amended and supplemented as follows: On January 21, 2026, the Reporting Person completed the Share Transfer (as defined in Item 4 of this Amendment), pursuant to which the Reporting Person transferred an aggregate of 258,367 Shares at a purchase price of $4.50 per Share, or $1,162,651.5 in the aggregate.
Item 4
Purpose of transaction
Item 4 of the Original Statement is hereby amended and supplemented as follows: The Reporting Person entered into share transfer agreements dated December 30, 2025 (the Share Transfer Agreements) and agreed to transfer (the Share Transfer) an aggregate of 258,367 Shares at a price of $4.50 per Share for aggregate proceeds of $1,162,651.5 as follows: Name of Transferee Number of Shares Proceeds Jeon Sungchan 258,367 $1,162,651.5 The Shares reported on this Amendment were transferred The Shares were transferred for liquidity purposes.
Item 5
Percentage of class
Item 5(a) of the Original Statement is hereby amended and restated as follows: The percentage of beneficial ownership reported in this Item 5, and on the Reporting Persons cover page to this Amendment, is based on a total of 6,373,869 shares of common stock, which represents the number of shares of common stock reported as outstanding on November 3, 2025, as reported in the Issuers Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025. All share numbers reported herein, and on the Reporting Persons cover page to this Amendment, are as of January 21, 2026, and give effect to the share transfers described herein. The cover page to this Amendment is incorporated by reference in its entirety into this Item 5. As of January 21, 2026, the Reporting Person is the beneficial owner of 1,598,947 shares of Common Stock, representing approximately 25.1% of the outstanding shares of Common Stock.
Item 6
Contracts and arrangements
Item 6 of the Original Statement is hereby supplemented as follows: The Reporting Person entered into share transfer agreements and agreed to transfer an aggregate of 258,367 Shares at a price of $4.50 per Share for aggregate proceeds of $1,162,651.5 as follows: Name of Transferee Number of Shares Proceeds Jeon Sungchan 258,367 $1,162,651.5
Signature 1
- Reporting person
- Exicure HiTron Inc.
- Signed
- Young Chul Han
- Title
- CEO
- Date
- 01/21/2026
Company context
Exicure, Inc. (Nasdaq: XCUR) is a biotechnology company focused on advancing innovative healthcare technologies and pursuing strategic growth opportunities. The Company’s portfolio includes a clinical-stage program targeting stem cell mobilization for multiple myeloma, sickle cell disease, and cell and gene therapy applications. Exicure is expanding its strategic focus to include medical device technologies designed to address unmet needs in Parkinson’s disease and other healthcare markets.